| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/08/2005 | US20050272027 Real-time clinical diagnostic systems for fluorescent spectrum analysis of tissue cells and methods thereof |
| 12/08/2005 | US20050272026 Test sample preparation part and detector for detecting scattered light and fluorescence from each cell in the test sample; for identifying living mononuclear cells in analytes more easily and rapidly |
| 12/08/2005 | US20050272025 Detecting a disruption or alteration in normal sub-cellular distribution of G-protein receptor kinases (GRKs), particularly GRK2 and GRK5 caused by abnormal accumulation of soluble beta -amyloid; method of correcting soluble beta-amyloid induced GRK dysfunction by administering a beta-amyloid antagonist |
| 12/08/2005 | US20050271723 Dosage forms for treatment of benign prostatic hyperplasia |
| 12/08/2005 | US20050271685 Cellular permissivity factor for viruses and uses thereof |
| 12/08/2005 | US20050271684 Apparatus and method for transdermal delivery of multiple vaccines |
| 12/08/2005 | US20050271678 Diagnostic compositions containing the polypeptide conjugated to a detectable label, such as radioisotopes, enzymes, fluorescent labels, antibody conjugates, or substrates |
| 12/08/2005 | US20050271670 Treatments for cancer |
| 12/08/2005 | US20050271667 Identification of a novel endothelial-derived gene EG-1 |
| 12/08/2005 | US20050271664 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 12/08/2005 | US20050271647 Chimeric pro-caspases and methods of using same |
| 12/08/2005 | US20050271644 Vitamin K epoxide recycling polypeptide VKORC1, a therapeutic target of coumarin and their derivatives |
| 12/08/2005 | US20050271641 Method for improved breast milk feeding to reduce the risk of allergy |
| 12/08/2005 | US20050271637 BMP-2 estrogen responsive element and methods of using the same |
| 12/08/2005 | US20050271632 Methods of modulating hair growth |
| 12/08/2005 | US20050271624 Use of apoptosis inducing agents in the treatment of (auto) immune diseases |
| 12/08/2005 | US20050271552 Analytical biochemistry system with robotically carried bioarray |
| 12/08/2005 | US20050268943 Microarray washing apparatus and method |
| 12/08/2005 | DE4419140B4 Verfahren zum Auffinden antimikrobischer Verbindungen A method for finding antimicrobial compounds |
| 12/08/2005 | DE202005006854U1 Low density biochip for immobilizing biomolecules, e.g. for use in immunoassays or DNA assays, of plastics with immobilization regions, having size and arrangement corresponding to 384 well microtiter plate |
| 12/08/2005 | DE102005020618A1 Verfahren und Systeme zur Erweiterung, Untersuchung, Verfeinerung und Analyse von biologischen Netzwerken Methods and systems for expansion, investigation, refinement and analysis of biological networks |
| 12/08/2005 | DE102004024432A1 Verwendung einer Folie mit hydrophiler Oberfläche in medizinischen Diagnosestreifen Use of a film having a hydrophilic surface in medical diagnostic strips |
| 12/08/2005 | DE102004023855A1 Schaltkreis-Anordnung Circuit arrangement |
| 12/08/2005 | DE102004023439A1 Nachweis von RNA über Micro-Arrays Detection of RNA on microarrays |
| 12/08/2005 | DE102004023188A1 Quality control process for the dairy industry, useful e.g. for selecting cultures with optimal properties, comprises detecting gene sequences indicative of quality by nucleic acid hybridization |
| 12/08/2005 | DE102004022435A1 Verfahren zur Herstellung löslicher MHC-Proteine Process for the preparation of soluble MHC proteins |
| 12/08/2005 | DE10085485B4 Verfahren zur Detektion des Mutationsgens dspp des hereditären opalisierenden Dentins Method for the detection of the mutation gene DSPP of hereditary opalescent dentin |
| 12/08/2005 | CA2822895A1 Influenza hemagglutinin and neuraminidase variants |
| 12/08/2005 | CA2590553A1 Method for identifying pde5-modulators |
| 12/08/2005 | CA2573304A1 Methods, kits and pharmaceutical compositions for diagnosing, delaying onset of, preventing and/or treating osteoporosis |
| 12/08/2005 | CA2572795A1 Differential expression of molecules associated with acute stroke |
| 12/08/2005 | CA2568537A1 Method for quantitative and/or comparative measurement of mrna expression levels in small biological samples |
| 12/08/2005 | CA2568201A1 Identification of ergothioneine transporter and therapeutic uses thereof |
| 12/08/2005 | CA2568020A1 Influenza hemagglutinin and neuraminidase variants |
| 12/08/2005 | CA2568019A1 Assay for transmissible spongiform encephalopathies |
| 12/08/2005 | CA2568015A1 Influenza hemagglutinin and neuraminidase variants |
| 12/08/2005 | CA2567937A1 Viral and viral associated mirnas and uses thereof |
| 12/08/2005 | CA2567822A1 Methods and devices for sequencing nucleic acids |
| 12/08/2005 | CA2567749A1 Methods for evaluating ribonucleotide sequences |
| 12/08/2005 | CA2567350A1 Use of gene expression profiling to predict survival in cancer patient |
| 12/08/2005 | CA2566498A1 Methods for treating cancer using anti-wnt2 monoclonal antibodies and sirna |
| 12/08/2005 | CA2566355A1 Influenza virus vaccine composition and methods of use |
| 12/08/2005 | CA2566214A1 Connector configuration for electrochemical cells and meters for use in combination therewith |
| 12/08/2005 | CA2563926A1 Transgenic models of alzheimer's disease and uses thereof in the treatment of a variety of neurodegenerative diseases |
| 12/08/2005 | CA2563613A1 Device for extracting biological molecules from tissue specimens |
| 12/08/2005 | CA2563314A1 Fcyriib-specific antibodies and methods of use thereof |
| 12/08/2005 | CA2562683A1 Adamts-8 proteins and uses thereof |
| 12/07/2005 | EP1602921A1 Apparatus and method for detecting bio molecule using inductance device |
| 12/07/2005 | EP1602736A1 HIV type and subtype detection |
| 12/07/2005 | EP1602735A2 Method and kit for the detection and/or quantification of homologous nucleotide sequences on arrays |
| 12/07/2005 | EP1602734A1 Dna amplification method and kit therefor |
| 12/07/2005 | EP1602733A1 Detection of target nucleotide sequences using an asymmetric oligonucleotide ligation assay |
| 12/07/2005 | EP1602732A2 Nucleic acid mutation detection by analysis of sputum |
| 12/07/2005 | EP1602731A1 The method of in vitro detecting aberrant dysplasia, and the artificial nucleotides being used |
| 12/07/2005 | EP1602724A1 Magnetic pigment |
| 12/07/2005 | EP1602723A1 Method of examining obesity or emaciation |
| 12/07/2005 | EP1602669A1 Antibody against tumor specific antigen as target |
| 12/07/2005 | EP1602666A1 Novel protein and its dna |
| 12/07/2005 | EP1601973A2 Use of the genes leprotl1 and ob-rgrp for the screening of active compounds for weight gain or loss or diabetes in human or animal subjects |
| 12/07/2005 | EP1601971A1 Diagnosis of gynecological neoplasms by detecting the levels of oviduct-specific glycoprotein |
| 12/07/2005 | EP1601968A2 Serum macrophage migration inhibitory factor (mif) as marker for prostate cancer |
| 12/07/2005 | EP1601966A2 Methods and compositions for purification of nucleic acid from a host cell |
| 12/07/2005 | EP1601949A2 Methods of evaluating caloric restriction and identifying caloric restriction mimetics |
| 12/07/2005 | EP1601947A2 Diagnostic test for west nile virus |
| 12/07/2005 | EP1601799A2 Methods and compositions for treating aids and hiv-related disorders using 9145, 1725, 311, 837, 58305, 156, 14175, 50352, 32678, 5560, 7240, 8865, 12396, 12397, 13644, 19938, 2077, 1735, 1786, 10220, 17822, 33945, 43748, 47161, 81982, or 46777 |
| 12/07/2005 | EP1601798A2 Probe biochips and methods for use thereof |
| 12/07/2005 | EP1601797A1 Diagnostic and prognostic compounds and method |
| 12/07/2005 | EP1601796A2 Standardized and optimized real-time quantitative reverse transcriptase polymerase chain reaction method for detection of mrd in leukemia |
| 12/07/2005 | EP1601795A2 Method for determining susceptibility of tumor to treatment with anti-neoplastic agent |
| 12/07/2005 | EP1601794A1 Method for identifying the function of a gene |
| 12/07/2005 | EP1601793A2 Methods for detection of genetic disorders |
| 12/07/2005 | EP1601792A1 Method for the identification of colorectal tumors |
| 12/07/2005 | EP1601791A2 Random array dna analysis by hybridization |
| 12/07/2005 | EP1601790A1 Nucleic acid biosensors |
| 12/07/2005 | EP1601789A2 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 12/07/2005 | EP1601788A1 Methods of tangential flow filtration and an apparatus therefore |
| 12/07/2005 | EP1601787A1 Dry reagent strip and nucleic acid detection |
| 12/07/2005 | EP1601786A1 Tagged polyfunctional reagents capable of reversibly binding target substances in a pH-dependent manner |
| 12/07/2005 | EP1601785A1 Methods for detection of genetic disorders |
| 12/07/2005 | EP1601784A2 Multiple controls for molecular genetic analyses |
| 12/07/2005 | EP1601783A2 Wheel motion control input device for animation system |
| 12/07/2005 | EP1601782A2 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8b (pde8b) |
| 12/07/2005 | EP1601781A2 Method and apparatus for environmental monitoring and bioprospecting |
| 12/07/2005 | EP1601780A2 Real time gene expression profiling |
| 12/07/2005 | EP1601779A2 Carboxylic acid reductase polypeptide, nucleotide sequence encoding same and methods of use |
| 12/07/2005 | EP1601775A1 Animal model for the fast identification of pharmaceutical active compounds in vivo |
| 12/07/2005 | EP1601770A2 Streptococcus pyogenes antigens |
| 12/07/2005 | EP1601767A2 USE OF ANTISENSE OLIGONUCLEOTIDES OR siRNA TO SUPPRESS EXPRESSION OF EIF-5A1 |
| 12/07/2005 | EP1601760A2 Nanopores, methods for using same, methods for making same and methods for characterizing biomolecules using same |
| 12/07/2005 | EP1601690A2 Production of plants with improved digestibility having an inactive peroxidase |
| 12/07/2005 | EP1601684A2 Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease |
| 12/07/2005 | EP1601682A2 Compositions and methods for diagnosing and treating prostate cancer |
| 12/07/2005 | EP1601576A2 Ligand/binding partner bio-labeling systems |
| 12/07/2005 | EP1601450A2 Liquid tissue preparation from histopatologically processed biological samples, tissues and cells |
| 12/07/2005 | EP1601332A2 Hydrolases, nucleic acids encoding them and mehods for making and using them |
| 12/07/2005 | EP1601325A2 Antisense oligonucleotides that inhibit expression of hif-1 |
| 12/07/2005 | EP1576188A4 Methods for using riboprimers for strand displacement replication of target sequences |
| 12/07/2005 | EP1373479A4 Methods for monitoring prothease inhibitor antiretroviral therapy |
| 12/07/2005 | EP1341931A4 Detection of dna damage |
| 12/07/2005 | EP1290451B1 Diagnosis of alzheimer's disease using ldl receptor protein-1 |